The leading market experts have placed a mean price target of $191.06 on Amgen Inc. (NASDAQ:AMGN) stock. This price level, which is estimated to be attained in one-year, indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $2.83 a share for the upcoming quarter and $11.37 for the current fiscal.
The technical analysis of Amgen Inc. plainly substantiates that the 50-day moving average of Amgen Inc. is $166.71, and stock is trading $6.53 points away or +3.92% from its 50-day moving average of $166.71. Further it is trading $17.55 or +11.27% away its 200-day moving average of $155.69. Amgen Inc. (NASDAQ:AMGN) 52-week high is $176.64 and the 52-week low is $130.09.
This explains if the stock moves $-3.40, it will post a 52-week high. In event of +33.17% decline, a 52-week low will be hit.
Taking the valuation aspect to emphasize the valuation of Amgen Inc., shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, Amgen Inc. (NASDAQ:AMGN) ratio came in at 17.73.
The stock last ended the trading session at $173.24 and registered a market cap of $129.65B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. Amgen Inc. (NASDAQ:AMGN) PEG ratio is at 1.81.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...